Pharmaceuticals and Contract Research Organizations
Heidrick & Struggles' Pharmaceuticals and Contract Research Organization team believes that while innovation still remains a foundational requirement for the future, so does a coherent plan on how best to lead the business and people towards a common objective. New leaders need to have strong relationship and influencing skills to align and integrate competing interests of complex stakeholder groups. With the constant pressure for growth, leaders with the ability to inspire, engage and drive high performance from their teams are currently in short supply.
We work extensively with the ‘big’ pharmaceuticals companies, but also have considerable experience in placing transformational leaders at specialty pharma, local and transnational generics, consumer healthcare, drug development centers and start-up organizations.
The pharmaceuticals industry today is in a transition phase. As organizations rush to adapt to changing business models and address key industry issues (patent cliff, generics, shareholder value, return on R&D, health reforms, Rx to OTC conversions, market access), they often overlook the people who are responsible for bringing in these changes – the leaders capable of taking them in the future.
However, what happens when transformation itself becomes an area of concern? How can organizations transform if the ‘drivers of change’ are not prepared for change? Heidrick & Struggles’ experts help clients mitigate these risks through recruiting, developing and retaining the talent that is able to address this imperative. Our consultants come from industry, academics and consulting backgrounds with many possessing medical and scientific qualifications. We align with clients in all major markets of the world and have significant experience in global assignments and emerging markets.
Our global reach ensures that while global trends impact local talent strategies, individual markets also learn from each other’s experience as they navigate through this maze. An unduly centralized or inappropriately decentralized model of leadership disconnected from the realities of the market place is no longer valid.